1. Home
  2. IMCR vs USA Comparison

IMCR vs USA Comparison

Compare IMCR & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

N/A

Current Price

$26.33

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Liberty All-Star Equity Fund

USA

Liberty All-Star Equity Fund

N/A

Current Price

$5.44

Market Cap

1.8B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IMCR
USA
Founded
2008
N/A
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
IMCR
USA
Price
$26.33
$5.44
Analyst Decision
Buy
Analyst Count
12
0
Target Price
★ $59.30
N/A
AVG Volume (30 Days)
414.0K
★ 1.4M
Earning Date
11-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 30.39
N/A
EPS
N/A
★ N/A
Revenue
★ $249,428,000.00
N/A
Revenue This Year
$9.28
N/A
Revenue Next Year
$9.91
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 43.05
N/A
52 Week Low
$26.53
$5.40
52 Week High
$40.71
$6.43

Technical Indicators

Market Signals
Indicator
IMCR
USA
Relative Strength Index (RSI) 32.57 27.27
Support Level N/A $5.40
Resistance Level $31.75 $5.95
Average True Range (ATR) 1.46 0.10
MACD -0.46 -0.06
Stochastic Oscillator 9.12 2.00

Price Performance

Historical Comparison
IMCR
USA

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a diversified, closed-end management investment company. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

Share on Social Networks: